BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 2329832)

  • 1. Three decades of treatment of esophageal squamous carcinoma at the Massachusetts General Hospital.
    Katlic MR; Wilkins EW; Grillo HC
    J Thorac Cardiovasc Surg; 1990 May; 99(5):929-38. PubMed ID: 2329832
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combined chemotherapy and radiotherapy followed by surgery in the treatment of patients with squamous cell carcinoma of the esophagus.
    Adham M; Baulieux J; Mornex F; de La Roche de Bransat E; Ducerf C; Souquet JC; Gerard JP
    Cancer; 2000 Sep; 89(5):946-54. PubMed ID: 10964323
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Esophageal cancer subtypes and survival rates at the VA Caribbean Healthcare System: a 10-year experience.
    González Ortiz DI; Toro DH
    Bol Asoc Med P R; 2009; 101(3):14-7. PubMed ID: 20120980
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Effort to radically cure stage III and IV esophageal carcinoma with simultaneous radiotherapy and chemotherapy in standard clinical practice].
    Farzad M; De Luca MC; Rubino G; Pirtoli L; Pepi F; Sebaste L; Ponticelli P; Atzeni G; Maranzano E; Silvano G
    Radiol Med; 2001; 102(1-2):72-7. PubMed ID: 11677442
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of maxillary sinus carcinoma: a comparison of the 1997 and 1977 American Joint Committee on cancer staging systems.
    Le QT; Fu KK; Kaplan M; Terris DJ; Fee WE; Goffinet DR
    Cancer; 1999 Nov; 86(9):1700-11. PubMed ID: 10547542
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Esophagectomy after concurrent chemoradiotherapy improves locoregional control in clinical stage II or III esophageal cancer patients.
    Liao Z; Zhang Z; Jin J; Ajani JA; Swisher SG; Stevens CW; Ho L; Smythe R; Vaporciyan AA; Putnam JB; Walsh GL; Roth JA; Yao JC; Allen PK; Cox JD; Komaki R
    Int J Radiat Oncol Biol Phys; 2004 Dec; 60(5):1484-93. PubMed ID: 15590179
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preoperative hyperfractionated chemoradiation for locally recurrent rectal cancer in patients previously irradiated to the pelvis: A multicentric phase II study.
    Valentini V; Morganti AG; Gambacorta MA; Mohiuddin M; Doglietto GB; Coco C; De Paoli A; Rossi C; Di Russo A; Valvo F; Bolzicco G; Dalla Palma M;
    Int J Radiat Oncol Biol Phys; 2006 Mar; 64(4):1129-39. PubMed ID: 16414206
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Management of stage IV glottic carcinoma: therapeutic outcomes.
    Spector GJ; Sessions DG; Lenox J; Newland D; Simpson J; Haughey BH
    Laryngoscope; 2004 Aug; 114(8):1438-46. PubMed ID: 15280724
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical study of modified Ivor-Lewis esophagectomy plus adjuvant radiotherapy for local control of stage IIA squamous cell carcinoma in the mid-thoracic esophagus.
    Chen G; Wang Z; Liu XY; Zhang MY; Liu FY
    Eur J Cardiothorac Surg; 2009 Jan; 35(1):1-7. PubMed ID: 18926712
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pretreatment T3-4 stage is an adverse prognostic factor in patients with esophageal squamous cell carcinoma who achieve pathological complete response following preoperative chemoradiotherapy.
    Chao YK; Chan SC; Liu YH; Chen HW; Wan YL; Chang HK; Fan KH; Liu HP
    Ann Surg; 2009 Mar; 249(3):392-6. PubMed ID: 19247024
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anal carcinoma or "just hemorrhoids"?
    Winburn GB
    Am Surg; 2001 Nov; 67(11):1048-58. PubMed ID: 11730221
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Squamous-cell carcinoma of the anal canal: predictors of treatment outcome.
    Roohipour R; Patil S; Goodman KA; Minsky BD; Wong WD; Guillem JG; Paty PB; Weiser MR; Neuman HB; Shia J; Schrag D; Temple LK
    Dis Colon Rectum; 2008 Feb; 51(2):147-53. PubMed ID: 18180997
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Squamous cell carcinoma of the esophagus.
    Estes NC; Stauffer J; Romberg M; Thomas JH; Jewell WR; Hermreck A
    Am Surg; 1996 Jul; 62(7):573-6. PubMed ID: 8651554
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Analysis of treatment results for oral tongue cancer.
    Sessions DG; Spector GJ; Lenox J; Haughey B; Chao C; Marks J
    Laryngoscope; 2002 Apr; 112(4):616-25. PubMed ID: 12150512
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Influence of number of metastatic lymph nodes on survival of curative resected thoracic esophageal cancer patients and value of radiotherapy: report of 549 cases.
    Xiao ZF; Yang ZY; Miao YJ; Wang LH; Yin WB; Gu XZ; Zhang DC; Sun KL; Chen GY; He J
    Int J Radiat Oncol Biol Phys; 2005 May; 62(1):82-90. PubMed ID: 15850906
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Factors affecting postoperative course and survival after en bloc resection for esophageal carcinoma.
    Mariette C; Taillier G; Van Seuningen I; Triboulet JP
    Ann Thorac Surg; 2004 Oct; 78(4):1177-83. PubMed ID: 15464466
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Management of T3N0M0 glottic carcinoma: therapeutic outcomes.
    Sessions DG; Lenox J; Spector GJ; Newland D; Simpson J; Haughey BH; Chao KS
    Laryngoscope; 2002 Jul; 112(7 Pt 1):1281-8. PubMed ID: 12169914
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Accurate lymph node assessment prior to trimodality therapy for esophageal carcinoma.
    Suntharalingam M; Haas ML; Sonett JR; Doyle LA; Hausner PF; Schuetz J; Greenwald B; Krasna MJ
    Cancer J; 2001; 7(6):509-15. PubMed ID: 11769864
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Analysis of treatment results for base of tongue cancer.
    Sessions DG; Lenox J; Spector GJ; Chao C; Chaudry OA
    Laryngoscope; 2003 Jul; 113(7):1252-61. PubMed ID: 12838028
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Local recurrence and survival rate after rectal cancer operations and multimodal therapy].
    Thomschke D; Kyau-Ummen B; Halbfass HJ
    Chirurg; 2002 Mar; 73(3):245-54. PubMed ID: 11963499
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.